Partner With Us NRI

Max Healthcare Institute Ltd share Price

Company details

6M Return 31.69%
1Y Return 59.67%
Mkt Cap.(Cr) 55,313.48
Volume 4,518,069
Div Yield 0.18%
OI Chg %
Volume 4,518,069

Open Free Trading Account Online with ICICIDIRECT

Max Healthcare Institute Ltd.

Q4FY23 Quarterly & FY23 Annual Result Announced for Max Healthcare Institute Ltd.

Max Healthcare Institute announced Q4FY23 & FY23 results:

  • Gross Revenue stood at Rs 1,637 crore for Q4FY23, 26% growth YoY & 5% growth QoQ
  • Network Operating EBITDA touched a new high of Rs 437 crore, growth of 44% YoY and 4% QoQ
  • Operating Margin stood at 28.2% versus 24.8% in Q4FY22 and 28.3% in Q3FY23
  • EBITDA per bed improved to Rs 70.3 lakhs in Q4FY23, from Rs 56.4 lakhs in Q4FY22 and Rs 66.9 lakhs in Q3FY23
  • PAT stood at Rs 320 crore in Q4FY23 versus Rs 172 crore in Q4FY22 and Rs 269 crore in Q3 FY23
  • Cash from Operations was Rs 425 crore in Q4FY23, of this Rs 65 crore spent towards ongoing capacity expansion projects; Net Cash as on Mar 31, 2023 stood at Rs 733 crore
  • Gross Revenue in FY23 stood at Rs 6,234 crore, up 18%, Network Operating EBITDA in FY23 was Rs 1,636 crore, an increase of 25%
  • Bed occupancy in Q4FY23 stood at 77%. Commissioned 92 beds for new Oncology block at Max Shalimar Bagh in March 2023
  • ARPOB improved to Rs 70.7k in Q4FY23 vs. Rs 63.5k in Q4FY22 and 66.8K in Q3FY23
  • Free treatment provided to 36,606 patients in OPD and 1,194 patients in IPD from the economically weaker sections
  • Board has recommended a dividend of Rs 1 per Share (10% of Face Value) for shareholder’s approval.

Commenting on Q4 results, Mr. Abhay Soi, Chairman and Managing Director, Max Healthcare Institute Ltd., said: “The Q4 results are in line with our plan and reflect the flawless execution of our strategy by the team on the ground. I am happy that we could deliver the first brownfield expansion on time and it has started to make positive addition to EBITDA and demonstrate operating leverage from the very first month. As other planned bed additions start to roll-in, we expect significant operating leverage.

In addition, we are actively but prudently evaluating inorganic growth opportunities

While we continue to see great investment opportunities in the sector, happy to announce that Board has recommended a maiden dividend of 10% for financial year ended Mar 31, 2023.”

Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Max Healthcare Institute Ltd Stocks COMPARISION


Equity Capital: 6,282.47 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 7,434.08 30,851.81
LAST 3M 18,139.88 59,059.53
LAST 6M 65,342.23 45,150.76
LAST 12M 117,520.45 98,037.67

Max Healthcare Institute Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Max Healthcare Institute Limited is an India-based healthcare company with a market capitalisation of Rs. 35,729.35 crore as of April 5, 2022. It owns and operates hospital chains across Delhi, National Capital Region (NCR), North India, and Mumbai. The company was incorporated on June 18, 2001, and its revenue touched Rs. 2,505 crore in the financial year 2021-22. Max Healthcare shares are listed on the Bombay Stock Exchange (BSE) as well as the National Stock Exchange (NSE) under the number 543220 and scrip code MAXHEALTH, respectively.

    Max Healthcare Limited is an Indian company that runs a chain of hospitals that specialise in providing treatment for cancer, oncology, neurosciences, cardiac sciences, orthopaedics, liver transplant, kidney transplant, bone marrow transplant, nephrology, and laparoscopic surgery, among others. The company also provides pathology and diagnostic services to its patients through a variety of channels, including self-owned and third-party diagnostic centres. The majority of Max Healthcare hospitals are located in Delhi, the National Capital Region (NCR), northern parts of India, and western Mumbai.

    The company was founded in 2000 and its first hospital was opened in the same year in South Delhi’s Panchsheel Park. It opened two more hospitals in 2002 in Northwest Delhi and Eastern Delhi. In 2011, Max Healthcare Limited signed a public-private partnership agreement with the government of Punjab to set up two hospitals in Mohali and Bathinda. It witnessed acquisitions and mergers with several hospitals during the process, including Pushpanjali Crosslay Hospital in Vaishali, Saket City Hospital in Saket, Radiant Lifecare, and the iconic Nanavati Hospital in Mumbai, and soon became the second-largest healthcare company in India in terms of revenues. The total number of employees of this company stood at 3,783 in 2020. The Managing Director of the company, Abhay Soi, holds 23.1% shares in the company, other promoters 37.54%, FII investors 16.67%, public investors 6.97%, and 15.58% are invested in mutual funds.

    As of April 5, 2022, Max Healthcare’s share price closed at Rs. 369.40 at the NSE. The 52-week high for Max Health share is Rs. 458.05 and the 52-week low is Rs. 212.00. Max Healthcare shares have provided one-year returns of 61.06%.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543220
Book Closure Date (Month) :
BSE Group : A
ISIN : INE027H01010

FAQ’s on Max Healthcare Institute Ltd Shares

You can buy Max Healthcare Institute Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Max Healthcare Institute Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 09, 2023 03:58 PM the closing price of Max Healthcare Institute Ltd was ₹ 569.70.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 09, 2023 03:58 PM, the market cap of Max Healthcare Institute Ltd stood at ₹ 55,313.48.

The latest PE ratio of Max Healthcare Institute Ltd as of Jun 09, 2023 03:58 PM is 50.22

The latest PB ratio of Max Healthcare Institute Ltd as of Jun 09, 2023 03:58 PM is 0.13

The 52-week high of Max Healthcare Institute Ltd is ₹ 577.40 while the 52-week low is ₹ 344.40

Download Our App

market app
market app